Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2000Haemophilia

Efficacy of a sucrose‐formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A

View Full Paper
Ask AI
Bookmark
Share

Authors

ISI. ScharrerJohannes Gutenberg University MainzHBH.‐H. BrackmannUniversity of BonnSYSultan YUniversity of Balamand

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Scharrer et al. (2000) studied this question.

synapsesocial.com/papers/6a97fed32855ae6cf374df84https://doi.org/10.1046/j.1365-2516.2000.00432.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Multicenter Study of Recombinant Factor VIII (RecombinateTM) in Previously Treated Patients with Hemophilia A1997 · 120 citations
  2. 2A Multicenter Pharmacosurveillance Study for the Evaluation of the Efficacy and Safety of Recombinant Factor VIII in the Treatment of Patients with Hemophilia A1997 · 47 citations
  3. 3Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A1990 · 268 citations
  4. 4Clotting factor concentrates and immune function in haemophilic patients1998 · 21 citations
  5. 5Second Generation, B-Domain Deleted Recombinant Factor VIII1997 · 59 citations